Emmy D.G. Fleuren

1.7k total citations
25 papers, 871 citations indexed

About

Emmy D.G. Fleuren is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Emmy D.G. Fleuren has authored 25 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Emmy D.G. Fleuren's work include Sarcoma Diagnosis and Treatment (14 papers), CAR-T cell therapy research (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). Emmy D.G. Fleuren is often cited by papers focused on Sarcoma Diagnosis and Treatment (14 papers), CAR-T cell therapy research (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). Emmy D.G. Fleuren collaborates with scholars based in Netherlands, Australia and United Kingdom. Emmy D.G. Fleuren's co-authors include Winette T.A. van der Graaf, Roger J. Daly, Luxi Zhang, Jianmin Wu, Yvonne M.H. Versleijen‐Jonkers, Otto C. Boerman, Ingrid M.E. Desar, Chris T. Williamson, Christopher J. Lord and Inger Brandsma and has published in prestigious journals such as Nature reviews. Cancer, The EMBO Journal and Cancer Research.

In The Last Decade

Emmy D.G. Fleuren

25 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emmy D.G. Fleuren Netherlands	17	497	368	307	108	98	25	871
Hayriye V. Erkizan United States	15	657 1.3×	236 0.6×	415 1.4×	114 1.1×	125 1.3×	20	981
Ogan D. Abaan United States	11	801 1.6×	298 0.8×	320 1.0×	219 2.0×	221 2.3×	14	1.2k
Daniela Lötsch Austria	17	461 0.9×	282 0.8×	147 0.5×	159 1.5×	36 0.4×	23	947
Gareth Hughes United Kingdom	13	694 1.4×	627 1.7×	321 1.0×	266 2.5×	80 0.8×	22	1.3k
Graham H.P. Richmond United Kingdom	5	492 1.0×	473 1.3×	321 1.0×	175 1.6×	63 0.6×	6	947
Julie S. Barber-Rotenberg United States	8	350 0.7×	204 0.6×	243 0.8×	43 0.4×	73 0.7×	11	608
Max Hallin United States	6	362 0.7×	276 0.8×	260 0.8×	142 1.3×	56 0.6×	6	632
Yun Oh United States	18	561 1.1×	373 1.0×	310 1.0×	137 1.3×	64 0.7×	28	1.0k
Yoko Ueno Japan	13	901 1.8×	377 1.0×	217 0.7×	123 1.1×	150 1.5×	19	1.4k
Antonella Perotti Italy	12	230 0.5×	316 0.9×	142 0.5×	97 0.9×	59 0.6×	25	591

Countries citing papers authored by Emmy D.G. Fleuren

Since Specialization

Citations

This map shows the geographic impact of Emmy D.G. Fleuren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmy D.G. Fleuren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmy D.G. Fleuren more than expected).

Fields of papers citing papers by Emmy D.G. Fleuren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmy D.G. Fleuren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmy D.G. Fleuren. The network helps show where Emmy D.G. Fleuren may publish in the future.

Co-authorship network of co-authors of Emmy D.G. Fleuren

This figure shows the co-authorship network connecting the top 25 collaborators of Emmy D.G. Fleuren. A scholar is included among the top collaborators of Emmy D.G. Fleuren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmy D.G. Fleuren. Emmy D.G. Fleuren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fleuren, Emmy D.G., Myrella Vlenterie, & Winette T.A. van der Graaf. (2023). Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma. Frontiers in Oncology. 13. 1013359–1013359. 19 indexed citations

Brown, Lauren M., Paul G. Ekert, & Emmy D.G. Fleuren. (2023). Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers. Oncogene. 42(23). 1875–1888. 11 indexed citations

Terry, Rachael, Déborah Meyran, Emmy D.G. Fleuren, et al.. (2021). Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma. Cancers. 13(18). 4704–4704. 14 indexed citations

Fleuren, Emmy D.G., Rachael Terry, Déborah Meyran, et al.. (2021). Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase Inhibitors. Biomedicines. 9(12). 1798–1798. 7 indexed citations

Ekert, Paul G., et al.. (2021). Precision medicine and phosphoproteomics for the identification of novel targeted therapeutic avenues in sarcomas. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876(2). 188613–188613. 9 indexed citations

Hillebrandt-Roeffen, Melissa H.S., Uta Flucke, Thomas Mentzel, et al.. (2020). Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo. Journal of Cancer Research and Clinical Oncology. 146(7). 1659–1670. 21 indexed citations

Versleijen‐Jonkers, Yvonne M.H., et al.. (2018). Targeted Therapy–based Combination Treatment in Rhabdomyosarcoma. Molecular Cancer Therapeutics. 17(7). 1365–1380. 26 indexed citations

Desar, Ingrid M.E., Emmy D.G. Fleuren, & Winette T.A. van der Graaf. (2018). Systemic Treatment for Adults with Synovial Sarcoma. Current Treatment Options in Oncology. 19(2). 13–13. 66 indexed citations

Jones, Samuel E., Emmy D.G. Fleuren, Jessica Frankum, et al.. (2017). ATR Is a Therapeutic Target in Synovial Sarcoma. Cancer Research. 77(24). 7014–7026. 47 indexed citations

10.

Hillebrandt-Roeffen, Melissa H.S., et al.. (2017). Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib. Targeted Oncology. 12(6). 815–826. 23 indexed citations

11.

Fleuren, Emmy D.G., Luxi Zhang, Jianmin Wu, & Roger J. Daly. (2016). The kinome 'at large' in cancer. Nature reviews. Cancer. 16(2). 83–98. 201 indexed citations

12.

Vlenterie, Myrella, Melissa H.S. Hillebrandt-Roeffen, Uta Flucke, et al.. (2016). Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients. Annals of Surgical Oncology. 23(9). 2745–2752. 32 indexed citations

13.

Fleuren, Emmy D.G., Yvonne M.H. Versleijen‐Jonkers, Otto C. Boerman, & Winette T.A. van der Graaf. (2014). Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: Current hurdles and future perspectives. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1845(2). 266–276. 35 indexed citations

14.

Fleuren, Emmy D.G., Yvonne M.H. Versleijen‐Jonkers, Sandra Heskamp, et al.. (2014). Theranostic applications of antibodies in oncology. Molecular Oncology. 8(4). 799–812. 49 indexed citations

15.

Fleuren, Emmy D.G., Yvonne M.H. Versleijen‐Jonkers, Melissa H.S. Roeffen, et al.. (2013). Abstract 2761: Temsirolimus is effective as a single agent and in combination with cisplatin or bevacizumab in preclinical osteosarcoma models.. Cancer Research. 73(8_Supplement). 2761–2761. 3 indexed citations

16.

Fleuren, Emmy D.G., Yvonne M.H. Versleijen‐Jonkers, Sandra Heskamp, et al.. (2013). The strength of small: Improved targeting of Insulin-like Growth Factor-1 Receptor (IGF-1R) with F(ab′)2-R1507 fragments in Ewing sarcomas. European Journal of Cancer. 49(13). 2851–2858. 10 indexed citations

17.

Fleuren, Emmy D.G., Yvonne M.H. Versleijen‐Jonkers, Addy C.M. van de Luijtgaarden, et al.. (2011). Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507. Clinical Cancer Research. 17(24). 7693–7703. 37 indexed citations

18.

Fleuren, Emmy D.G., Sandra O’Toole, Ewan K.A. Millar, et al.. (2010). Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development. International Journal of Cancer. 127(6). 1486–1492. 22 indexed citations

19.

Brummer, Tilman, Mark Larance, Paul Timpson, et al.. (2009). The docking protein and proto-oncogene product Gab2 is regulated via a novel negative feedback mechanism mediated by 14-3-3 binding. Cell Communication and Signaling. 7(S1). 4 indexed citations

20.

Brummer, Tilman, Mark Larance, Maria Teresa Herrera Abreu, et al.. (2008). Phosphorylation‐dependent binding of 14‐3‐3 terminates signalling by the Gab2 docking protein. The EMBO Journal. 27(17). 2305–2316. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact